Carlyle injects capital into Chinese lab operator

                        The private equity firm has invested in Adicon at a time when demand for private healthcare is growing in China.

                        Carlyle injects capital into Chinese lab operator

                        Carlyle has bought a controlling stake in Adicon, winning a competitive auction for the Chinese clinical laboratory operator.

                        The private equity firm invested alongside Meinian Onehealth Healthcare, it said in a statement on Monday. Carlyle acquired a 13.5% stake in Meinian Onehealth Healthcare in 2012.

                        Last month, Meinian subsidiary Haimei Ai Investment Management signalled its intentions to buy a 5% stake in Adicon for $22 million, valuing the entire company at $440...

                        FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

                        Click for more on: carlyle | health | china

                        Print Edition

                        FinanceAsia Print Edition